Technical Analysis for BOLT - Bolt Biotherapeutics, Inc.

Grade Last Price % Change Price Change
F 22.87 -2.14% -0.50
BOLT closed down 3.27 percent on Thursday, May 6, 2021, on approximately normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical BOLT trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish -1.03%
Down 3 Days in a Row Weakness -1.03%
20 DMA Support Bullish -4.26%
20 DMA Support Bullish -4.62%
Crossed Above 20 DMA Bullish -6.09%
20 DMA Resistance Bearish 3.44%
Wide Bands Range Expansion 3.44%
Fell Below 20 DMA Bearish -4.42%
Wide Bands Range Expansion -4.42%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -11.07%
Older End-of-Day Signals for BOLT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % 43 minutes ago
Down 1% about 1 hour ago
Possible NR7 about 1 hour ago
10 DMA Resistance about 1 hour ago
60 Minute Opening Range Breakdown about 2 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors. Its preclinical stage product candidates include carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. Bolt Biotherapeutics, Inc. was founded in 2015 and is based Redwood city, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Pharmaceutical Products Cancer Immunotherapy Tumors Her2/Neu Immune Checkpoint Breast Cancers

Is BOLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 43.07
52 Week Low 20.87
Average Volume 253,205
200-Day Moving Average 0.00
50-Day Moving Average 28.72
20-Day Moving Average 24.05
10-Day Moving Average 24.65
Average True Range 2.45
ADX 17.78
+DI 14.60
-DI 21.90
Chandelier Exit (Long, 3 ATRs ) 20.94
Chandelier Exit (Short, 3 ATRs ) 28.21
Upper Bollinger Band 26.66
Lower Bollinger Band 21.43
Percent B (%b) 0.37
BandWidth 21.76
MACD Line -1.19
MACD Signal Line -1.39
MACD Histogram 0.1994
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.01
Resistance 3 (R3) 26.09 25.29 25.57
Resistance 2 (R2) 25.29 24.62 25.25 25.42
Resistance 1 (R1) 24.33 24.20 23.93 24.25 25.28
Pivot Point 23.53 23.53 23.33 23.49 23.53
Support 1 (S1) 22.57 22.86 22.17 22.49 21.46
Support 2 (S2) 21.77 22.44 21.73 21.32
Support 3 (S3) 20.81 21.77 21.17
Support 4 (S4) 20.73